Синоприл

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Синоприл

What is Синоприл?

Property Description
Active ingredient Lisinopril (as dihydrate salt)
Form Oral tablet, Oral solution
Pharmacological class Angiotensin-Converting Enzyme (ACE) Inhibitor
Common use Management of High Blood Pressure
Origin Synthetic peptide derivative

What Type of Medicine is Синоприл (Lisinopril)?

Синоприл is a prescription medication whose active substance is Lisinopril, a compound classified as an Angiotensin-Converting Enzyme (ACE) Inhibitor. This class of medication identifies the drug as a foundational agent for managing cardiovascular health. Lisinopril is a synthetic peptide derivative intended for systemic use and is primarily supplied for oral administration as a tablet or oral solution. As a foundational drug, it is developed as a single-ingredient product, containing only Lisinopril to achieve its therapeutic effect, distinguishing it from combination treatments.

What is the Primary Function of an ACE Inhibitor?

The primary function of Синоприл is to act as an antihypertensive agent by regulating the body's natural systems that control blood pressure. The medication achieves this by inhibiting the Angiotensin-Converting Enzyme (ACE), thereby promoting vasodilation (widening of blood vessels). ACE inhibitors are key medications for lowering blood pressure and improving overall heart function. This class of medication helps the heart pump with less effort, which is the primary general benefit.

What Makes Lisinopril Unique Among ACE Inhibitors?

Lisinopril possesses structural differences that set it apart from some other drugs in its class. Notably, it is not a prodrug, which means the substance is fully active in its administered form and does not require initial processing by the liver to become effective. This structure means Lisinopril starts working directly without needing to be chemically altered by the body. Furthermore, Lisinopril is one of the few ACE inhibitors that exhibits high water-solubility, a distinct chemical identity.

What side effects are possible with Синоприл?

Possible Side Effects and Safety Information

The safety profile for Синоприл (Lisinopril) is officially documented by government regulatory authorities, organizing potential adverse reactions by frequency and physiological system. Common adverse reactions (occurring in 1% or more of patients) reported in clinical trials and regulatory summaries include cough, headache, dizziness, and low blood pressure (hypotension).


System-Organ Classifications and Serious Risks

Adverse reactions are classified by the affected organ system. Reactions involving the Respiratory System are commonly characterized by a persistent, dry cough, while Vascular Disorders include hypotension.

The label highlights specific, clinically significant serious adverse reactions. These include Angioedema, which is a potentially severe swelling of the face, tongue, and throat that can occur at any time during treatment. Symptomatic hypotension is also documented as a risk, particularly upon the initiation of therapy or during dose changes. Furthermore, the risk of clinically significant Hyperkalemia (elevated serum potassium) and changes in Renal Function necessitate periodic monitoring as described in the official prescribing information.


Population-Specific Safety Constraints

The medicine is subject to strict regulatory constraints regarding specific populations. Fetal Toxicity is a major safety concern, as the drug is contraindicated during the second and third trimesters of pregnancy due to the risk of injury or death to the fetus. The use of Синоприл is also contraindicated in individuals with a history of Angioedema related to previous treatment with an ACE inhibitor. Safety and effectiveness have not been established for use in children younger than six years of age.

Overdose and Emergency Response

Overdose and When to Seek Help

The most serious clinical sign of a Синоприл (Lisinopril) overdose is severe hypotension (dangerously low blood pressure), which is an extreme over-exaggeration of the drug’s primary effect. Documented manifestations may include fainting (syncope), lightheadedness, mental confusion, vomiting, and tachycardia (rapid heartbeat). Overdose carries a risk of life-threatening events, including circulatory collapse and the potential development of acute renal failure due to compromised blood flow to the kidneys.

Mandated Emergency Action

Immediate medical attention is required if an overdose is suspected. Government guidance states that emergency services (e.g., 911 or equivalent) must be contacted immediately if the person has collapsed, experienced a seizure, has trouble breathing, or cannot be awakened (stupor/unconsciousness). Furthermore, a Poison Control center should be contacted for procedural guidance.

Official Management and Monitoring

Management of overdose is strictly symptomatic and supportive. There is no specific pharmacological antidote documented. Procedures focus on stabilizing blood pressure, typically by placing the patient in a supine position and administering an intravenous saline infusion. Patients must be kept under very close observation, with mandatory monitoring of blood pressure, renal function, and serum potassium levels to manage the associated risks.

Therapeutic Uses of Синоприл

What Синоприл (Lisinopril) Treats: Main Uses and Benefits

Синоприл is generally used for the long-term management of high blood pressure (hypertension). It addresses symptoms related to systemic imbalance and vascular strain that elevated pressure places on the arteries. The medication is considered relevant for easing symptomatic manifestations in key areas, primarily: high blood pressure, chronic heart failure, and supportive care following major cardiac events. The primary therapeutic benefit supports consistent blood pressure management, which contributes to easing the overall symptom load associated with high blood pressure.

The medication is commonly used as a supportive treatment for chronic heart failure in adults. It assists with managing symptom clusters related to impaired cardiac pumping function, such as fluid retention and reduced physical capacity. This support contributes to improved comfort during periods of heightened symptoms, and may help patients cope more steadily with symptom fluctuations.

“Applied across domains where additional symptomatic support is needed, Синоприл plays a role in managing functional stability.”

Синоприл is also relevant in clinical settings marked by heightened cardiovascular and renal risk. This includes being applied across domains where additional symptomatic support is needed and assists with maintaining functional stability for kidney health in patients with diabetes. Applied when symptoms create noticeable physiological strain, it supports patients during episodes of heightened discomfort and is relevant for easing symptoms linked to organ-specific functional stress.


Quick Fact: Relief for Systemic Strain Синоприл is commonly used to help manage the symptoms of vascular strain and cardiac workload associated with high blood pressure, contributing to better day-to-day comfort.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Who Can and Cannot Use Синоприл? (Lisinopril)

Синоприл (Lisinopril), an ACE inhibitor, is not safe or appropriate for all individuals and is strictly defined by regulatory guidance. Official guidelines state that the medicine is contraindicated in specific populations to prevent serious harm.

Contraindications and Prohibited Use

  • Pregnancy: Use is strictly contraindicated during the second and third trimesters, and the medicine must be discontinued as soon as pregnancy is detected due to the risk of fetal injury or death.
  • Allergic Reactions: It is prohibited for use in patients with a history of angioedema (severe swelling) related to prior ACE inhibitor treatment, or in those with hereditary or idiopathic angioedema.
  • Drug Combinations: Use is contraindicated in patients with diabetes or moderate-to-severe renal impairment who are taking Aliskiren. It is also prohibited for at least 36 hours after the last dose of a neprilysin inhibitor (e.g., Sacubitril/Valsartan).

Restrictions and Special Considerations

  • Pediatric Use: Safety and effectiveness are not established for children under six years of age for hypertension.
  • Lactation: Use is not recommended in breastfeeding women.
  • Severe Cardiac or Renal Conditions: Treatment must not be initiated in patients with acute heart attack who have low blood pressure or cardiogenic shock. Caution and dose adjustment are required for patients with impaired kidney function.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Interactions with Angiotensin-Converting Enzyme (ACE) inhibitors primarily stem from the risk of increased hypotension and significant electrolyte imbalances, especially hyperkalemia (elevated potassium levels).

Product Class/Category Interaction Concern Regulatory Classification/Note
Neprilysin Inhibitors (e.g., sacubitril/valsartan) High risk of angioedema (swelling of the face, mouth, or throat). Contraindicated. Do not co-administer.
Aliskiren Increased risk of hyperkalemia, hypotension, and impaired kidney function. Contraindicated in patients with diabetes or moderate-to-severe kidney impairment (GFR < 60 mL/min).
Potassium-Sparing Diuretics (e.g., amiloride, spironolactone) & Potassium Supplements Significant risk of severe hyperkalemia (high potassium). Use with extreme caution and require frequent monitoring of serum potassium and kidney function.
Nonsteroidal Anti-inflammatory Drugs (NSAIDs) May reduce the blood pressure-lowering effect and increase the risk of severe kidney function decline, especially in volume-depleted or older patients. Requires close monitoring of kidney function.
Lithium ACE inhibitors can decrease lithium excretion, leading to potentially toxic serum lithium levels. Serum lithium levels must be monitored carefully.
Antidiabetic Agents (e.g., insulin, oral hypoglycemics) Increased risk of hypoglycemia (low blood sugar), particularly at the start of ACE inhibitor therapy. Requires close monitoring of blood glucose.

Mechanism of Action

How Синоприл Works

Синоприл functions as a pro-drug and is hydrolyzed primarily by esterase enzymes into its active metabolite, cilazaprilat (or its active equivalent). This active compound acts as a competitive inhibitor of the angiotensin-converting enzyme (ACE), which is a key component of the renin-angiotensin-aldosterone system (RAAS). ACE inhibition blocks the conversion of the decapeptide angiotensin I into the potent octapeptide vasoconstrictor, angiotensin II.

The resulting reduction in circulating and localized angiotensin II leads to multiple downstream effects. It decreases direct arteriolar vasoconstriction and reduces the synthesis and release of aldosterone from the adrenal cortex. Lowered aldosterone activity promotes a modest natriuretic effect and reduces water retention. The combined effect of decreased vasoconstriction and reduced fluid volume contributes to decreased peripheral vascular resistance and a subsequent reduction in cardiac afterload. Additionally, ACE inhibition interferes with the degradation of bradykinin, a vasodilator, which further contributes to the observed systemic vasodilation.

Dosage and Administration Information

How to Use Синоприл (Lisinopril) — Administration Guidelines

Синоприл is exclusively intended for oral administration, primarily available as a tablet form in multiple strengths (e.g., 2.5 mg to 40 mg). Its administration schedule is consistently defined as once daily across all approved uses, and it may be taken with or without food.

Administration Schedule and Dosing

Standard dosing rules establish a low starting dose, which is subsequently adjusted through titration over several weeks. For hypertension in adults, treatment is typically initiated with a 10 mg dose once daily, with a usual maintenance range of 20 mg to 40 mg. For heart failure, the initial dose is lower, starting at 2.5 mg to 5 mg once daily, and slowly increased as tolerated toward the maximum permitted daily dose.

Administration Scope Standard Administration
Route of Administration Oral (Tablet or liquid solution).
Frequency Pattern Once daily (Single daily dose).
Timing in Relation to Meals May be taken independently of food intake.

Population-Specific Procedural Rules

Initial dose modifications are based on the patient's underlying physiological condition. Patients with impaired renal function (creatinine clearance le 30 mL/min) are initiated at a reduced dose, sometimes as low as 2.5 mg once daily, to account for the slower elimination of the medication. Furthermore, a reduced 5 mg starting dose is also applied to hypertensive adults already receiving a diuretic. The protocol for use in acute cardiac events often requires a minimum six-week duration of therapy.

Recent Clinical Evidence

Research evidence / Overview of studies for Синоприл (Lisinopril)

This overview summarizes the official research conducted on Синоприл (Lisinopril), detailing the types of studies that have been completed, the outcomes those studies monitored, and the areas where information is still emerging or uncertain. Findings describe group patterns, not personal outcomes or individual predictions.


Evidence for Use in High Blood Pressure (Hypertension)

Синоприл was studied for high blood pressure in trials that primarily involved Randomized Controlled Trials ( RCTs) and comparative studies. Research examined outcomes such as the change in systolic and diastolic blood pressure readings and changes in Left Ventricular Mass index. Studies report how symptoms evolved in the observed populations, with findings indicate patterns related to BP measurements that varied in the studied groups compared to controls.


Evidence for Use in Chronic Heart Failure

Синоприл was evaluated in adults with systolic heart failure in multiple large- scale survival studies and meta- analyses. Key outcomes monitored included outcomes related to all- cause mortality, cardiovascular mortality rates, and hospitalization frequency. Survival studies tracked patients for specific durations, with one major trial following subjects for a median of 46 months. Findings regarding all- cause mortality patterns when compared to placebo were mixed in some reviews.


Evidence for Use Following Acute Myocardial Infarction

Синоприл was evaluated in large- scale trials following an acute myocardial infarction ( AMI) in adults who were hemodynamically stable. Research examined outcomes related to total mortality rates at a 6- week follow- up point, and monitored the incidence of severe Left Ventricular Dysfunction ( LVD). Data are still emerging for outcomes beyond the 6- month follow- up period.


Evidence for Use in Kidney Health (Diabetic Nephropathy)

Синоприл was evaluated in studies examining kidney health in hypertensive patients with Type 1 or Type 2 diabetes and microalbuminuria. Studies tracked the change in albuminuria or proteinuria levels and the rate of change in GFR. A change in GFR measurement was observed in some studies when the medicine was first applied, followed by a different pattern of measurement over time. Evidence is limited for non- diabetic Chronic Kidney Disease patients with increased albuminuria.

Frequently Asked Questions (FAQ)

Common questions about Синоприл (FAQ)

Q: What is Sinopril used for besides high blood pressure?

Official information states that Sinopril (Lisinopril) is indicated for more than just high blood pressure. It is also approved for treating the symptoms of systolic heart failure. Additionally, it is used to reduce the risk of death in patients who are hemodynamically stable after suffering an acute myocardial infarction (heart attack).


Q: What are the main benefits of Sinopril for people with heart failure?

The main clinical benefit noted in official documentation is the reduction of signs and symptoms associated with systolic heart failure. This benefit is typically achieved when the medication is used as an add-on to other standard therapies, such as diuretics.


Q: Does Sinopril help prevent heart attack or stroke?

While Sinopril is not solely marketed as a preventative medicine for these events, official data confirm that lowering blood pressure is a critical factor in reducing the overall risk of fatal and non-fatal cardiovascular events. This includes conditions like stroke and myocardial infarction.


Q: Why is Sinopril prescribed after a heart attack?

According to regulatory sources, Sinopril is prescribed to patients who are stable after an acute myocardial infarction (heart attack) specifically to help reduce the risk of death (mortality). This is a validated indication supported by clinical trials.


Q: Is Sinopril considered a long-acting drug?

Yes, Sinopril is classified as a long-acting antihypertensive medication. Its effect lasts approximately 24 hours, which is why it is typically taken only once per day, as stated in the official product information.


Q: Can Sinopril cause dizziness or loss of balance?

Dizziness and feeling faint or lightheaded are listed among the more common side effects, especially when transitioning quickly from sitting or lying down to standing. If dizziness becomes severe, individuals should seek the guidance of a healthcare professional.


Q: Is feeling tired or weak associated with taking Sinopril?

Yes, official safety information indicates that unusual tiredness or weakness is reported as one of the more common side effects of this medication.


Q: Can Sinopril affect taste or smell?

Regulatory data indicates that a change or disturbance in the sense of taste, known as dysgeusia, is a possible side effect of Sinopril. This is generally categorized as less common.


Q: Can temporary blurred vision occur while taking Sinopril?

Yes, official product information lists blurred vision as one of the more common adverse effects that can occur while taking Sinopril.


Q: Does Sinopril lead to skin rash or itching?

Yes, a rash and itching are noted in the safety information. They are listed as possible signs of an allergic reaction, which can sometimes be an early indicator of a serious condition like angioedema.


Q: Can Sinopril cause stomach upset or diarrhea?

Official safety information indicates that gastrointestinal issues, including nausea, vomiting, or diarrhea, are listed among the less common side effects. Any persistent digestive distress is generally recommended to be discussed with a medical professional.


Q: What signs of angioedema (swelling of the face or throat) should I be aware of?

Official regulatory sources highlight that angioedema is a serious risk, and any noticeable sign of it warrants immediate medical evaluation. Signs include hoarseness, difficulty breathing or swallowing, or any swelling of the face, lips, tongue, or throat.


Q: What symptoms indicate possible kidney problems while taking Sinopril?

While laboratory tests are the primary way to monitor kidney function, observable signs may include a noticeable decrease in the amount of urine produced or a change in its concentration. Monitoring of kidney function, typically through blood tests, is periodically recommended as stated in the product information.


Q: How can Sinopril affect liver function?

Official safety data confirms the medication can cause changes in liver function tests. Although rare, serious liver injury has been reported, and if symptoms like pain in the upper belly or loss of appetite occur, medical evaluation should be sought immediately.


Q: Why might some people experience severe abdominal pain while taking Sinopril?

Severe abdominal pain, sometimes accompanied by nausea or vomiting, can be a symptom of a rare but serious side effect known as intestinal angioedema. This condition generally warrants prompt medical evaluation.


Q: Can Sinopril cause blood problems (changes in blood tests)?

Official information indicates a potential increased risk of blood problems, which may show up as changes in blood cell counts. This risk is notably higher for patients who already have co-existing conditions, particularly kidney disease.


Q: How quickly does Sinopril start to lower blood pressure?

Regulatory sources show that the onset of the blood pressure-lowering activity typically begins within one hour after taking the tablet by mouth.


Q: How long does it take for Sinopril to reach its maximum effect?

The greatest reduction in blood pressure usually occurs approximately six hours after the dose is taken. This marks the peak effect of the medication during the 24-hour dosing cycle.


Q: How long do I need to take Sinopril?

Sinopril is designed to control chronic conditions like hypertension and heart failure, rather than curing them. Therefore, it is generally intended for long-term use. Abruptly stopping the medication is generally not recommended.


Q: What can happen if I suddenly stop taking Sinopril?

Official cautionary statements note that abrupt discontinuation may lead to uncontrolled high blood pressure. In patients with heart or kidney issues, sudden cessation can result in the worsening of those conditions.


Q: Is there a difference in effectiveness if I take Sinopril in the morning or evening?

The administration schedule requires taking the medication once daily. Regulatory guidance stresses that the consistency of taking the dose every day is more important than the specific time (morning or evening).


Q: How does drinking alcohol affect Sinopril?

Official caution statements note that consuming alcohol while taking this medication can cause an adverse interaction. This may increase the risk of side effects, particularly making you more susceptible to hypotension (low blood pressure).


Q: Is there a risk of interaction with herbal or dietary supplements?

Due to the limited available research on the interaction between Sinopril and herbal or dietary supplements, official caution is advised. It is generally advisable to inform a healthcare provider about all supplements being taken.


Q: Does Sinopril reduce the risk of chronic kidney disease?

Studies involving hypertensive patients with diabetes show that Sinopril helps reduce the amount of protein (albumin) in the urine. This action is considered a measure of protection, reducing strain on the kidneys.


Q: Is dose adjustment of Sinopril necessary for elderly people?

Official guidelines note that elderly patients may require a dose adjustment, particularly if they have age-related decline in kidney function. This is part of the standard caution for dosing in this population.


Q: Can Sinopril be less effective for some populations?

Official product information indicates that antihypertensive agents of this class, when used alone (monotherapy), may exhibit a reduced blood pressure-lowering effect in Black patients.


Q: Does Sinopril affect heart rate (pulse)?

Official studies show that Sinopril typically causes little to no change in the heart rate. When blood pressure drops, the heart does not respond with compensatory tachycardia (a rapid increase in heart rate).


Q: What blood tests are required regularly when taking Sinopril?

To safely manage therapy, regulatory documents require periodic monitoring of specific blood parameters. This typically includes measuring serum potassium levels and key indicators of kidney function, such as creatinine.


Q: What is the FDA "Boxed Warning" associated with Sinopril?

The Boxed Warning is the FDA’s most stringent regulatory alert used to draw attention to serious risks. For Sinopril, this warning specifically concerns the significant risk of injury or death to the fetus if the drug is taken during the second and third trimesters of pregnancy.


Q: How long does Sinopril stay in the body after stopping?

According to pharmacokinetic data, the effective half-life (the time it takes for half the drug concentration to be eliminated) is about 12.6 hours. The terminal half-life, which represents the complete elimination time, is about 46.7 hours.


Q: What should I do if I miss a dose of Sinopril?

The recommended approach if a dose is missed is to take it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the instruction is to skip the missed one entirely. It is a core safety instruction that two doses should never be taken at once to compensate for a missed dose.


Q: Can Sinopril cause sexual side effects?

Official safety information lists decreased interest in sexual intercourse (libido) and problems achieving or maintaining an erection as less common side effects associated with this medication.


Q: Does Sinopril affect weight change?

Clinical studies generally do not indicate measurable weight gain or weight loss directly caused by Sinopril. However, as fluid retention is sometimes a concern with cardiovascular conditions, swelling or edema may be possible.

How should Синоприл be stored and disposed of?

How to Store and Dispose of Синоприл ( Lisinopril)

The storage and disposal of this medication are governed by strict regulatory standards to preserve its stability and potency.

Labeled Storage Temperature Requirements: Controlled Room Temperature (20 C to 25 C), with excursions permitted between 15 C and 30 C.
Light/Moisture Protection: The product must be protected from moisture, excessive heat, and freezing, and some formulations require protection from light.
Packaging and Handling Rules: Keep the medicine in its original container, which must be kept tightly closed. It is mandatory to store Синоприл out of the reach of children.
Official Disposal Rules: Unused or expired medication must be disposed of in accordance with local/regional regulations. Patients should consult their pharmacist for specific instructions on discarding the product safely.

These requirements strictly define the environmental constraints and safety measures for the product, preventing chemical degradation and accidental access.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Синоприл found in:

A-Z Index: